RxDoctor Payments Data

Betsy Joyner

Physician Assistant · Raleigh, NCNPI 1962953182

Payments from drug & device makers

$2,124in general payments, 2019–2025

Across 115 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$724
  • Lilly USA, LLC$200
  • Boehringer Ingelheim$158
  • AstraZeneca$113
  • Pfizer$104
  • Abbott$87
  • plus $737 from 18 others

What the payments were for

  • Food & beverage$2,11299%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,124 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$16,573
TradjentaLinagliptin18$16,004
OzempicSemaglutide14$15,902
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,691
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$3,582
Dexlansoprazole DrDexlansoprazole11$1,744
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,119
Colestipol Hcl12$1,057
Albuterol Sulfate HfaAlbuterol Sulfate14$567
Carbamazepine12$484
Atorvastatin Calcium68$386
Losartan Potassium28$272
Metformin Hcl29$211
Celecoxib21$205
Amlodipine Besylate31$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$158$32,57833 claims
Novo NordiskOzempic$724$15,90214 claims
GSKTrelegy Ellipta$48$7,69112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →